Han Ying
Directeur Technique/Scientifique/R&D chez IMMUNOTECH BIOPHARM LTD
Profil
Han Ying is the founder of Gene Corp., which was founded in 2021.
Dr. Ying is currently the Chief Executive Officer & Director at Gyre Therapeutics, Inc. since 2023 and the Chief Scientific Officer at Immunotech Biopharm Ltd.
Dr. Ying previously worked as a Director at Base Therapeutics.
Dr. Ying obtained a doctorate degree from Stanford University and completed undergraduate and graduate degrees from Peking University.
Postes actifs de Han Ying
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOTECH BIOPHARM LTD | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Han Ying
| Sociétés | Poste | Fin |
|---|---|---|
Gene Corp.
 Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Fondateur | - |
Formation de Han Ying
| Stanford University | Doctorate Degree |
| Peking University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOTECH BIOPHARM LTD | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gene Corp.
Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Retail Trade |
